A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy
Clinical trial NCT02001987 · COMPLETED
Trial details
- NCT number
- NCT02001987
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-12-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.